Botulinum toxin type A for the treatment of postamputation residual limb myokymia: a case report.
Dave
Shashank J
SJ
Department of Physical Medicine and Rehabilitation, and Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Salyer
Joshua
J
Desai
Kevin A
KA
D000671:Amputation, Surgical / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D035002:Lower Extremity; D008875:Middle Aged; D020385:Myokymia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D009465:Neuromuscular Agents / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A